Systemic lupus erythematosus–driven accelerated atherosclerosis: the immune–metabolic–vascular axis and therapeutic implications

• by Meiwei Jiang, FengQi Zhang, MinZhe Ren, ZhiYu Li, ZhiJun Xie, Jing Sun

• June 10, 2026

Semaglutide Use Linked to Erythromelalgia Remission

Case details diagnostic workup and rapid symptom resolution following GLP-1 receptor agonist initiation.

• by Kathryn Wighton

• April 22, 2026

• 4 min

Organ Damage, BMI Linked to Fatigue in SLE

Cross-sectional study suggests fatigue is associated with damage accrual and body mass, not disease activity

• by Andrea Surnit

• April 20, 2026

• 3 min

Comparative effectiveness and safety of biologics and targeted small-molecule therapies plus stable background therapy in systemic lupus erythematosus: a systematic review and network meta-analysis

• by Wenjuan Li, Yanhong Zhao, Siyan Shu, Ran Li, Yu Huang, Yuanyuan Gong, Guanhua Zhao, Yuxin Fan, Jianchang He

• May 1, 2026